Jupiros 10 Tablet contains Rosuvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL particles from the bloodstream. Jupiros 10 is prescribed to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization in patients with established coronary artery disease or multiple risk factors. It is also utilized in the management of homozygous familial hypercholesterolemia. The recommended dose is individualized based on patient response and lipid levels, with regular monitoring of liver function tests and lipid profiles advised during therapy. Common adverse effects include headache, myalgia, and gastrointestinal disturbances, while rare but serious effects such as myopathy and hepatotoxicity require prompt medical attention. Jupiros 10 should be used cautiously in patients with hepatic impairment and contraindicated during pregnancy and lactation.